{
  "success": true,
  "sourceFile": "input/EliLilly_NCT03421379_Diabetes_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26
  ],
  "modelUsed": "gemini-2.5-pro",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "All Entered Set Population",
        "populationType": "Disposition",
        "instanceType": "AnalysisPopulation",
        "label": "AES",
        "description": "All patients who sign inform consent and enter in this study",
        "criteria": "Signed informed consent and entered the study"
      },
      {
        "id": "pop_2",
        "name": "All Randomized Set Population",
        "populationType": "Disposition",
        "instanceType": "AnalysisPopulation",
        "label": "ARS",
        "description": "All patients who are randomized to study treatments",
        "criteria": "Randomized to a study treatment"
      },
      {
        "id": "pop_3",
        "name": "Full Analysis Set Population",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FAS",
        "description": "All randomized patients who receive at least 1 dose of study drug. This population is used for safety analyses and efficacy analyses other than the primary outcome.",
        "criteria": "Randomized and received at least 1 dose of study drug"
      },
      {
        "id": "pop_4",
        "name": "Efficacy Analysis Set Population",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "EAS",
        "description": "Patients in the FAS and have evaluable primary efficacy outcome",
        "criteria": "Member of the Full Analysis Set with an evaluable primary efficacy outcome"
      },
      {
        "id": "pop_5",
        "name": "PK/PD Population",
        "populationType": "Pharmacokinetic/Pharmacodynamic",
        "instanceType": "AnalysisPopulation",
        "label": "PK/PD",
        "description": "Patients in the FAS and have evaluable PK/PD.",
        "criteria": "Member of the Full Analysis Set with evaluable Pharmacokinetic/Pharmacodynamic data"
      },
      {
        "id": "pop_6",
        "name": "Safety Analysis Set",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "label": "SAF",
        "description": "All randomized patients who receive at least 1 dose of study drug. Per the SAP, safety analyses are conducted on the Full Analysis Set (FAS).",
        "criteria": "Randomized and received at least 1 dose of study drug"
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "Age",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Age of the subject at baseline"
      },
      {
        "id": "char_2",
        "name": "Sex",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Sex of the subject"
      },
      {
        "id": "char_3",
        "name": "Race",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Race of the subject"
      },
      {
        "id": "char_4",
        "name": "Ethnicity",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Ethnicity of the subject"
      },
      {
        "id": "char_5",
        "name": "Body Weight",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Body weight at baseline"
      },
      {
        "id": "char_6",
        "name": "Height",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Height at baseline"
      },
      {
        "id": "char_7",
        "name": "Body Mass Index",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Body Mass Index (BMI) at baseline"
      },
      {
        "id": "char_8",
        "name": "Diabetes Type",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Type of diabetes mellitus (Type 1 or Type 2)"
      },
      {
        "id": "char_9",
        "name": "Duration of Diabetes",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Duration of diabetes in years at baseline"
      },
      {
        "id": "char_10",
        "name": "Baseline HbA1c",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Baseline Glycated Hemoglobin (HbA1c) value (%)"
      },
      {
        "id": "char_11",
        "name": "Baseline Clarke Hypoglycemia Awareness Status",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Hypoglycemia awareness status at baseline, assessed by the Clarke questionnaire"
      },
      {
        "id": "char_12",
        "name": "Baseline Substance Use (Alcohol)",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Alcohol use at baseline"
      },
      {
        "id": "char_13",
        "name": "Previous Diabetic Therapy",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "History of previous therapies for diabetes"
      }
    ],
    "summary": {
      "populationCount": 6,
      "characteristicCount": 13
    }
  }
}